Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis

Figure 5

The drug sensitivity analysis of (a) axitinib, (b) bexarotene, (c) bicalutamide, (d) bleomycin, (e) camptothecin, (f) dasatinib, (g) docetaxel, (h) erlotinib, and (i) gemcitabine.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)